Bruker's Q2 earnings show recovery from COVID-19

By The Science Advisory Board staff writers

August 3, 2021 -- Bruker's second-quarter earnings report illustrates recovery from the COVID-19 pandemic, with a 34% increase in revenue compared to the same period in 2020.

The company reported that revenue was up by 34.4%, totaling $570.8 million, with good performance in its divisions. Bruker Scientific Instruments' revenue was up year over year by 34.9% to $517.1 million, and Bruker Energy and Supercon Technologies was up 26.3% to $56.6 million.

The results reflect strong demand for Bruker products and a strong recovery compared to the same period in 2020, the company said.

Bruker also reported an increase in operating income under generally accepted accounting principles (GAAP), with $85.6 million reported in the second quarter of 2021 compared with $37.9 million in 2020. The company reported a diluted GAAP earnings per share of 38¢ for the second quarter (compared with 16¢ in 2020) and a non-GAAP diluted earnings per share of 44¢ compared with 21¢ in the same period of 2020.

Based on performance so far this year, the company raised its guidance for revenue, operating margins, and non-GAAP earnings per share in 2021.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.